Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial-Reference-Cited by-同舟云学术

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

Published:2014-11 Issue:11 Volume:13 Page:1100-1107
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Dodick David W,Goadsby Peter J,Silberstein Stephen D,Lipton Richard B,Olesen Jes,Ashina Messoud,Wilks Kerri,Kudrow David,Kroll Robin,Kohrman Bruce,Bargar Robert,Hirman Joe,Smith Jeff

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference29 articles.

1. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society;Silberstein;Neurology,2012

2. The use of migraine preventive medications among patients with and without migraine headaches;Lafata;Cephalalgia,2010

3. Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study;Scher;Cephalalgia,2010

4. Tolerance and loss of beneficial effect during migraine prophylaxis: clinical considerations;Loder;Headache,2011

5. Adherence with migraine prophylaxis in clinical practice;Berger;Pain Pract,2012

Cited by 319 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and Tolerability of Anti-Calcitonin Gene-Related Peptide Therapy for Migraine and Other Chronic Headaches in Adolescents and Young Adults: A Retrospective Study in the USA;Brain Sciences;2024-08-30

2. Revolutionizing migraine management: advances and challenges in CGRP-targeted therapies and their clinical implications;Frontiers in Neurology;2024-06-13

3. A real‐world prospective observational study of eptinezumab in Asian patients with migraine;Headache: The Journal of Head and Face Pain;2024-05-24

4. Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review;Journal of Clinical Medicine;2024-03-28

5. Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports;Journal of Clinical Medicine;2024-03-24